Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(5E)-14-chloro-15,17-dihydroxy-4,7,8,9,10,11-hexahydro-2-benzoxacyclopentadecine-1,12(3H,13H)-dione
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of hydroxybenzoic acid derivatives and aromatic heteropolycyclic compounds[1][4]. It has the molecular formula C18H21ClO5 and a molecular weight of approximately 352.81 g/mol[2][4]. The drug is experimental and not approved for any indication; there are no known clinical trials or approved uses as of now[1][3]. Its mechanism of action is not fully characterized in public sources; however it has been associated with interaction studies involving heat shock protein HSP90-beta (gene HSP90AB1), suggesting possible activity as an HSP90 inhibitor or modulator[8].
- Other names
- 14-chloro-15,17-dihydroxy-1,3,4,7,8,9,10,11,12,13-decahydro-2-benzoxacyclopentadecine-1,12-dione2-benzoxacyclopentadecin-1,12(3H,13H)-dione 14-chloro-4.7.8.9.10.11 hexahydro 15.17 dihydroxy (5E)
02
Targets
HSP90AB1 (Heat shock protein HSP 90-beta)
Beyond the preview
Go deeper on (5E)-14-chloro-15,17-dihydroxy-4,7,8,9,10,11-hexahydro-2-benzoxacyclopentadecine-1,12(3H,13H)-dione.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (5E)-14-chloro-15,17-dihydroxy-4,7,8,9,10,11-hexahydro-2-benzoxacyclopentadecine-1,12(3H,13H)-dione.